MedTrace Logo

Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke

NCT05342038 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-06-07

No results posted yet for this study

Summary

To examine the revascularization efficacy and safety of T-02 and its associated performance characteristics in treatment of appropriately selected subjects experiencing an acute ischemic stroke when the treatment is initiated within 24 hours after last seen well under the current guideline, and to generate hypotheses to be confirmed in subsequent confirmatory clinical investigations

Conditions

  • Acute Ischemic Stroke
  • Large Vessel Occlusion
  • Vascular Occlusion
  • Thrombosis
  • Endovascular

Interventions

DEVICE

T-02

Stent retriever

Sponsors & Collaborators

  • Biomedical Solutions Inc.

    lead INDUSTRY

Principal Investigators

  • Igor J. Kocijančič, MD · University Medical Centre Ljubljana

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-22
Primary Completion
2023-01-31
Completion
2023-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05342038 on ClinicalTrials.gov